Research / LUNG / Fundamental state Inspectable configuration
State dimensions Filing 0001127537-25-000012 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
44.37% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.73% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-37.64% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
22.01% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
20.19% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
74.00% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-68.87% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
20.97% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
27.40% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/8 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 0/9 normalized Level 3 Mar 31, 2025 0/9 normalized Level 3 Jun 30, 2025 0/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 182.65%
Current 44.37%
Delta -138.27% Capex Intensity Decreased
Previous 2.04%
Current 1.73%
Delta -0.31% Cash Generation Decreased
Previous -35.52%
Current -37.64%
Delta -2.12% Growth Increased
Previous 15.39%
Current 22.01%
Delta 6.62% Inventory Pressure Decreased
Previous 83.19%
Current 20.19%
Delta -63.00% Margin Increased
Previous 73.70%
Current 74.00%
Delta 0.29% Profitability Increased
Previous -69.30%
Current -68.87%
Delta 0.44% R And D Intensity Increased
Previous 18.36%
Current 20.97%
Delta 2.60% Sbc Intensity Decreased
Previous 28.64%
Current 27.40%
Delta -1.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.